NCT03798561 - Study to Evaluate ASN008 Topical Gel (TG) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 14, 2019

Primary Completion Date

March 20, 2020

Study Completion Date

March 20, 2020

Conditions

Dermatitis, AtopicPruritusDermatitis Eczema

Interventions

DRUG

ASN008 TG

DRUG

Placebo TG

Trial Locations (5)

Certified Research Associates, Cortland

Dermatology Consulting Services, PLLC, High Point

Spaulding Research Clinic, Inc, West Bend

Progressive Clinical Research, San Antonio

Innovaderm Recherches Inc, Montreal